5-HT6 receptors: Contemporary views on their neurobiological and pharmacological relevance in neuropsychiatric disorders
Abdeslam Chagraoui, Florence Thibaut, Philippe De Deurwaerdère
Dialogues in Clinical Neuroscience. 2025-05-10
10.1080/19585969.2025.2502028

Cingulate cortex Stimulation drives distinct pupillary responses in rat via recruitment of noradrenergic neurons in the locus coeruleus
Vianney Salvi, Gilles Courtand, Philippe de Deurwaerdère, Laura Cardoit, Stéphane Valerio, Sébastien Delcasso, François Georges, Thomas Michelet
Cerebral Cortex. 2025-05-01
10.1093/cercor/bhaf085

Brief early-life motor training induces behavioral changes and alters neuromuscular development in mice
Camille Quilgars, Eric Boué-Grabot, Philippe de Deurwaerdère, Jean-René Cazalets, Florence E. Perrin, Sandrine S. Bertrand
PLoS Biol. 2025-04-21
10.1371/journal.pbio.3003153

Widespread and Heterologous Effects of L-DOPA on Monoaminergic Tissue Metabolism in Newborn Rats Expressing Air-Stepping
Grégory Barrière, Zora Pelloquin-Mvogo, Marie Boulain, Inès Khsime, Rahul Bharatiya, Marie-Anne Riquier, Didier Morin, Anne-Emilie Allain, Abdeslam Chagraoui, Laurent Juvin, Philippe De Deurwaerdere
IJMS. 2025-03-05
10.3390/ijms26052298

Brainstem serotonin amplifies nociceptive transmission in a mouse model of Parkinson’s disease
Zoé Grivet, Franck Aby, Aude Verboven, Rabia Bouali-Benazzouz, Benjamin Sueur, François Maingret, Frédéric Naudet, Thibault Dhellemmes, Philippe De Deurwaerdere, Abdelhamid Benazzouz, Pascal Fossat
npj Parkinsons Dis.. 2025-01-07
10.1038/s41531-024-00857-1

The psychoplastogens ibogaminalog and ibogainalog induce antidepressant-like activity in naïve and depressed mice by mechanisms involving 5-HT_2A receptor activation and serotonergic transmission.
Hugo R. Arias, Deborah Rudin, Dino Luethi, Jan Valenta, Anna Leśniak, Zofia Czartoryska, Agnieszka Olejarz-Maciej, Agata Doroz-Płonka, Dina Manetti, Philippe De Deurwaerdère, Maria Novella Romanelli, Jadwiga Handzlik, Matthias E. Liechti, Abdeslam Chagraoui
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2025-01-01
10.1016/j.pnpbp.2024.111217

Coronaridine congeners induce anticonvulsant activity in rodents by hippocampal mechanisms involving mainly potentiation of GABAA receptors
Hugo R. Arias, Paulina Kazmierska-Grebowska, Tomasz Kowalczyk, Yaeun Shim, Bartosz Caban, Chloé Aman, Anne-Emilie Allain, Philippe De Deurwaerdère, Abdeslam Chagraoui
European Journal of Pharmacology. 2024-11-01
10.1016/j.ejphar.2024.176911

Classical psychedelics’ action on brain monoaminergic systems
Jasmine Jade Butler, Daria Ricci, Chloé Aman, Anna Beyeler, Philippe De Deurwaerdère
The International Journal of Biochemistry & Cell Biology. 2024-09-01
10.1016/j.biocel.2024.106669

To what extent may aminochrome increase the vulnerability of dopaminergic neurons in the context of Parkinson's disease
Abdeslam Chagraoui, Youssef Anouar, Philippe De Deurwaerdere, Hugo R. Arias
The International Journal of Biochemistry & Cell Biology. 2024-03-01
10.1016/j.biocel.2024.106528

The novel non-hallucinogenic compound DM506 (3-methyl-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole) induces sedative- and anxiolytic-like activity in mice by a mechanism involving 5-HT2A receptor activation
Hugo R. Arias, Deborah Rudin, Dustin J. Hines, April Contreras, Alican Gulsevin, Dina Manetti, Youssef Anouar, Philippe De Deurwaerdere, Jens Meiler, Maria Novella Romanelli, Matthias E. Liechti, Abdeslam Chagraoui
European Journal of Pharmacology. 2024-03-01
10.1016/j.ejphar.2024.176329

Serotonergic neurons are involved in the counter-regulatory response to hypoglycemia.
Hugo Martin, Adeline Coursan, Justine Lallement, Mathieu Di Miceli, Janany Kandiah, Ilyès Raho, Jasmine Buttler, Jean‐Philippe Guilloux, Philippe De Deurwaerdere, Sophie Layé, Vanessa H. Routh, Bruno P. Guiard, Christophe Magnan, Céline Cruciani‐Guglielmacci, Xavier Fioramonti
J Neuroendocrinology. 2023-10-19
10.1111/jne.13344

Limiting Monoamines Degradation Increases L-DOPA Pro-Locomotor Action in Newborn Rats
Inès Khsime, Marie Boulain, Abderrahman Fettah, Abdeslam Chagraoui, Gilles Courtand, Philippe De Deurwaerdère, Laurent Juvin, Grégory Barrière
IJMS. 2023-09-29
10.3390/ijms241914747

Coronaridine congeners induce sedative and anxiolytic-like activity in naïve and stressed/anxious mice by allosteric mechanisms involving increased GABAA receptor affinity for GABA
Hugo R. Arias, Philippe De Deurwaerdère, Petra Scholze, Seiji Sakamoto, Itaru Hamachi, Giuseppe Di Giovanni, Abdeslam Chagraoui
European Journal of Pharmacology. 2023-08-01
10.1016/j.ejphar.2023.175854

Editorial: Insights on neuroinflammatory response by microglia-targeted pharmacology
Jacob Raber, Hector J. Caruncho, Philippe De Deurwaerdere, Massimo Grilli
Front. Pharmacol.. 2023-05-04
10.3389/fphar.2023.1205859

The metal brain
Philippe De Deurwaerdère, Yannick Crémillieux
Journal of Neuroscience Methods. 2023-02-01
10.1016/j.jneumeth.2022.109777

Editorial: New GPCR targets and modulators to treat CNS disorders
Philippe De Deurwaerdère, Evgeni Ponimaskin, Abdeslam Chagraoui, Giuseppe Di Giovanni
Front. Mol. Neurosci.. 2022-12-06
10.3389/fnmol.2022.1104336

Insulin modulates emotional behavior through a serotonin-dependent mechanism
Hugo Martin, Sébastien Bullich, Maud Martinat, Mathilde Chataigner, Mathieu Di Miceli, Vincent Simon, Samantha Clark, Jasmine Butler, Mareike Schell, Simran Chopra, Francis Chaouloff, Andre Kleinridders, Daniela Cota, Philippe De Deurwaerdere, Luc Pénicaud, Sophie Layé, Bruno P. Guiard, Xavier Fioramonti
Mol Psychiatry. 2022-10-07
10.1038/S41380-022-01812-3

In Vivo Study of Monoamine Oxidases Using Multisite Intracerebral Microdialysis
Philippe De Deurwaerdère, Nouhad Samb, Hasna El Boukhari, Rémi Corne, Abdeslam Chagraoui, Giuseppe Di Giovanni
Methods in Molecular Biology. 2022-09-29
10.1007/978-1-0716-2643-6_14

Deleting Snord115 genes in mice remodels monoaminergic systems activity in the brain toward cortico-subcortical imbalances
Virginie Marty, Jasmine J Butler, Basile Coutens, Oumaima Chargui, Abdeslam Chagraoui, Bruno P Guiard, Philippe De Deurwaerdère, Jérôme Cavaillé
Human Molecular Genetics. 2022-08-11
10.1093/HMG/DDAC139

Switch of serotonergic descending inhibition into facilitation by a spinal chloride imbalance in neuropathic pain
Franck Aby, Louis-Etienne Lorenzo, Zoé Grivet, Rabia Bouali-Benazzouz, Hugo Martin, Stéphane Valerio, Sara Whitestone, Dominique Isabel, Walid Idi, Otmane Bouchatta, Philippe De Deurwaerdere, Antoine G. Godin, Cyril Herry, Xavier Fioramonti, Marc Landry, Yves De Koninck, Pascal Fossat
Sci. Adv.. 2022-07-29
10.1126/sciadv.abo0689

Cannabinoid 1/2 Receptor Activation Induces Strain-Dependent Behavioral and Neurochemical Changes in Genetic Absence Epilepsy Rats From Strasbourg and Non-epileptic Control Rats
Philippe De Deurwaerdère, Maurizio Casarrubea, Daniel Cassar, Manuela Radic, Emilie Puginier, Abdeslam Chagraoui, Giuseppe Crescimanno, Vincenzo Crunelli, Giuseppe Di Giovanni
Front. Cell. Neurosci.. 2022-05-23
10.3389/FNCEL.2022.886033

Pathophysiology of the Serotonin System in the Nervous System and Beyond
Philippe De Deurwaerdère, Giuseppe Di Giovanni
IJMS. 2022-04-25
10.3390/ijms23094712

Neurobiological and Pharmacological Perspectives of D3 Receptors in Parkinson’s Disease
Abdeslam Chagraoui, Giuseppe Di Giovanni, Philippe De Deurwaerdère
Biomolecules. 2022-02-01
10.3390/biom12020243

Nicotine modulation of the lateral habenula/ventral tegmental area circuit dynamics: An electrophysiological study in rats
Massimo Pierucci, Francis Delicata, Roberto Colangeli, Antonella Marino Gammazza, Alessandro Pitruzzella, Maurizio Casarrubea, Philippe De Deurwaerdère, Giuseppe Di Giovanni
Neuropharmacology. 2022-01-01
10.1016/J.NEUROPHARM.2021.108859

Simulated Microgravity Subtlety Changes Monoamine Function across the Rat Brain
Alexandra Gros, Léandre Lavenu, Jean-Luc Morel, Philippe De Deurwaerdère
IJMS. 2021-10-29
10.3390/ijms222111759

L‐DOPA and 5‐HTP modulation of air‐stepping in newborn rats
Marie Boulain, Wei Yuan, Zied Oueghlani, Inès Khsime, Vianney Salvi, Gilles Courtand, Christophe Halgand, Didier Morin, Philippe Deurwaerdere, Grégory Barrière, Laurent Juvin
J Physiol. 2021-09-05
10.1113/jp281983

Dopamine D3 Receptor: Contemporary Views of Its Function and Pharmacology for Neuropsychiatric Diseases
Philippe De Deurwaerdère, Abdeslam Chagraoui
Biomolecules. 2021-05-11
10.3390/biom11050713

Lateral Habenula 5-HT2C Receptor Function Is Altered by Acute and Chronic Nicotine Exposures
Cristiano Bombardi, Francis Delicata, Claudio Tagliavia, Annamaria Grandis, Massimo Pierucci, Antonella Marino Gammazza, Maurizio Casarrubea , Philippe De Deurwaerdère and Giuseppe Di Giovanni
Int. J. Mol. Sci. 2021-04-30
10.3390/ijms22094775

Multiple facets of serotonergic modulation.
Anna Beyeler, Anes Ju, Abdeslam Chagraoui, Lise Cuvelle, Maxime Teixeira, Giuseppe Di Giovanni, Philippe De Deurwaerdère
Progress in Brain Research. 2021-01-01
10.1016/bs.pbr.2021.02.002

5-HT Interaction with Other Neurotransmitters: Experimental Evidence and Therapeutic Relevance Part B Preface
Giuseppe Di Giovanni, Philippe De Deurwaerdere
Progress in Brain Research. 2021-01-01
10.1016/S0079-6123(21)00083-2

5-HT interaction with other neurotransmitters: An overview
Philippe De Deurwaerdere, Giuseppe Di Giovanni
Progress in Brain Research. 2021-01-01
10.1016/BS.PBR.2021.01.001

Serotonergic control of the glutamatergic neurons of the subthalamic nucleus
Luisa Ugedo, Philippe De Deurwaerdère
Progress in Brain Research. 2021-01-01
10.1016/BS.PBR.2020.11.003

Serotonin modulation of hippocampal functions: From anatomy to neurotherapeutics
Cristiano Bombardi, Annamaria Grandis, Nela Pivac, Marina Sagud, Guillaume Lucas, Abdeslam Chagraoui, Valérie Lemaire-Mayo, Philippe De Deurwaerdère, Giuseppe Di Giovanni
Progress in Brain Research. 2021-01-01
10.1016/BS.PBR.2021.01.031

Serotonin/dopamine interaction: Electrophysiological and neurochemical evidence
Philippe De Deurwaerdère, Abdeslam Chagraoui, Giuseppe Di Giovanni
Progress in Brain Research. 2021-01-01
10.1016/BS.PBR.2021.02.001

Serotonin research: Crossing scales and boundaries
Giuseppe Di Giovanni, Philippe De Deurwaerdère
Neuropharmacology. 2020-12-01
10.1016/J.NEUROPHARM.2020.108340

Editorial: Contemporary Perspective on 5-HT2C Receptor Function and Its Pharmacological Targeting
Philippe De Deurwaerdère, Abdeslam Chagraoui, Kathryn A. Cunningham
Front. Pharmacol.. 2020-11-23
10.3389/FPHAR.2020.606414

A Subset of Purposeless Oral Movements Triggered by Dopaminergic Agonists Is Modulated by 5-HT2C Receptors in Rats: Implication of the Subthalamic Nucleus
Mélanie Lagière, Marion Bosc, Sara Whitestone, Abdelhamid Benazzouz, Abdeslam Chagraoui, Mark J. Millan, Philippe De Deurwaerdère
IJMS. 2020-11-12
10.3390/ijms21228509

Mediterranean Neuroscience Methods 2019.
Philippe De Deurwaerdère, Salvatore Galati, Giuseppe Di Giovanni
Journal of Neuroscience Methods. 2020-11-01
10.1016/j.jneumeth.2020.109010

Editorial: Non-Dopaminergic Systems in Parkinson's Disease
Cristina Miguelez, Philippe De Deurwaerdère, Véronique Sgambato
Front. Pharmacol.. 2020-09-11
10.3389/FPHAR.2020.593822

Chronic Administration of Fipronil Heterogeneously Alters the Neurochemistry of Monoaminergic Systems in the Rat Brain
Rahul Bharatiya, Abdeslam Chagraoui, Salomé De Deurwaerdere, Antonio Argiolas, Maria Rosaria Melis, Fabrizio Sanna, Philippe De Deurwaerdere
IJMS. 2020-08-09
10.3390/ijms21165711

Lorcaserin Alters Serotonin and Noradrenaline Tissue Content and Their Interaction With Dopamine in the Rat Brain
Giuseppe Di Giovanni, Rahul Bharatiya, Emilie Puginier, Marta Ramos, Salomé De Deurwaerdère, Abdeslam Chagraoui, Philippe De Deurwaerdère
Front. Pharmacol.. 2020-06-30
10.3389/fphar.2020.00962

Serotonin in Health and Disease
Philippe De Deurwaerdère, Giuseppe Di Giovanni
IJMS. 2020-05-15
10.3390/ijms21103500

The Noradrenergic System in Parkinson’s Disease
Elena Paredes-Rodriguez, Sergio Vegas-Suarez, Teresa Morera-Herreras, Philippe De Deurwaerdere, Cristina Miguelez
Front. Pharmacol.. 2020-04-08
10.3389/fphar.2020.00435

Lorcaserin bidirectionally regulates dopaminergic function site-dependently and disrupts dopamine brain area correlations in rats
Philippe De Deurwaerdère, Marta Ramos, Rahul Bharatiya, Emilie Puginier, Abdeslam Chagraoui, Julien Manem, Eleonora Cuboni, Massimo Pierucci, Gabriele Deidda, Maurizio Casarrubea, Giuseppe Di Giovanni
Neuropharmacology. 2020-04-01
10.1016/j.neuropharm.2019.107915

The pesticide fipronil injected into the substantia nigra of male rats decreases striatal dopamine content: A neurochemical, immunohistochemical and behavioral study
Rahul Bharatiya, Jessica Bratzu, Carla Lobina, Giulia Corda, Cristina Cocco, Philippe De Deurwaerdere, Antonio Argiolas, Maria Rosaria Melis, Fabrizio Sanna
Behavioural Brain Research. 2020-04-01
10.1016/j.bbr.2020.112562

Acute and chronic nicotine exposures differentially affect central serotonin 2A receptor function: Focus on the lateral habenula
Cristiano Bombardi, Francis Delicata, Claudio Tagliavia, Massimo Pierucci, Gabriele Deidda, Maurizio Casarrubea, Philippe De Deurwaerdère, Giuseppe Di Giovanni
IJMS. 2020-03-09
10.3390/ijms21051873

Serotonin in Animal Cognition and Behavior
Julien Bacqué-Cazenave, Rahul Bharatiya, Grégory Barrière, Jean-Paul Delbecque, Nouhaila Bouguiyoud, Giuseppe Di Di Giovanni, Daniel Cattaert, Philippe De Deurwaerdère
IJMS. 2020-02-28
10.3390/ijms21051649

Old neurochemical markers, new functional directions?
Philippe De Deurwaerdere, Silvana Gaetani, Roxanne A. Vaughan
J. Neurochem.. 2020-01-09
10.1111/jnc.14929

Constitutive activity of 5-HT receptors: Factual analysis
Philippe De Deurwaerdère, Rahul Bharatiya, Abdeslam Chagraoui, Giuseppe Di Giovanni
Neuropharmacology. 2020-01-01
10.1016/j.neuropharm.2020.107967

Serotonergic control of excitability: from neuron to networks
Giuseppe Di Giovanni, Abdeslam Chagraoui, Rahul Bharatiya, Philippe De Deurwaerdère
Handbook of Behavioral Neuroscience. 2020-01-01
10.1016/B978-0-444-64125-0.00010-4

Motivation and motivational aspects of Parkinson’s disease
Abdeslam Chagraoui, Emilie Puginier, Philippe De Deurwaerdère
Genetics, Neurology, Behavior, and Diet in Parkinson's Disease. 2020-01-01
10.1016/B978-0-12-815950-7.00031-X

L-DOPA in Parkinson's Disease: Looking at the "False" Neurotransmitters and Their Meaning.
Chagraoui A, Boulain M, Juvin L, Anouar Y, Barrière G, Deurwaerdère P
Int J Mol Sci.. 2019 Dec 31
10.3390/ijms21010294.

L-DOPA in parkinson’s disease: Looking at the “false” neurotransmitters and their meaning
Chagraoui, Boulain, Juvin, Anouar, Barrière, Deurwaerdère
IJMS. 2019-12-31
10.3390/ijms21010294

Early neurochemical modifications of monoaminergic systems in the R6/1 mouse model of Huntington's disease
Emilie Puginier, Rahul Bharatiya, Abdeslam Chagraoui, Julien Manem, Yoon H. Cho, Maurice Garret, Philippe De Deurwaerdère
Neurochemistry International. 2019-09-01
10.1016/j.neuint.2019.05.001

Reciprocal interaction between monoaminergic systems and the pedunculopontine nucleus: Implication in the mechanism of L-DOPA
Giuseppe Di Giovanni, Abdeslam Chagraoui, Emilie Puginier, Salvatore Galati, Philippe De Deurwaerdère
Neurobiology of Disease. 2019-08-01
10.1016/j.nbd.2018.08.014

Effect of the 5-HT2C Receptor Agonist WAY-163909 on Serotonin and Dopamine Metabolism across the Rat Brain: A Quantitative and Qualitative Neurochemical Study
Sara Whitestone, Philippe De Deurwaerdère, Lynn Baassiri, Julien Manem, Youssef Anouar, Giuseppe Di Giovanni, Rahul Bharatiya, Abdeslam Chagraoui
IJMS. 2019-06-14
10.3390/ijms20122925

Neurochemical impact of the 5-HT 2C receptor agonist WAY-163909 on monoamine tissue content in the rat brain
Abdeslam Chagraoui, Sara Whitestone, Lynn Baassiri, Julien Manem, Giuseppe Di Giovanni, Philippe De Deurwaerdère
Neurochemistry International. 2019-03-01
10.1016/j.neuint.2019.01.019

TCB-2 [(7R)-3-bromo-2, 5-dimethoxy-bicyclo[4.2.0]octa-1,3,5-trien-7-yl]methanamine]: A hallucinogenic drug, a selective 5-HT 2A receptor pharmacological tool, or none of the above?
Giuseppe Di Giovanni, Philippe De Deurwaerdère
Neuropharmacology. 2018-11-01
10.1016/j.neuropharm.2017.10.004

Exogenous LRRK2G2019S induces parkinsonian-like pathology in a nonhuman primate
Nadine Mestre-Francés, Nicolas Serratrice, Aurélie Gennetier, Gina Devau, Sandra Cobo, Stéphanie G. Trouche, Pascaline Fontès, Charleine Zussy, Philippe De Deurwaerdere, Sara Salinas, Franck J.D. Mennechet, Julien Dusonchet, Bernard L. Schneider, Isabella Saggio, Vasiliki Kalatzis, M. Rosario Luquin-Piudo, Jean-Michel Verdier, Eric J. Kremer
JCI Insight. 2018-07-25
10.1172/jci.insight.98202

Alteration of nociceptive integration in the spinal cord of a rat model of Parkinson's disease
Keri-Ann Charles, Frédéric Naudet, Rabia Bouali-Benazzouz, Marc Landry, Philippe De Deurwaerdère, Pascal Fossat, Abdelhamid Benazzouz
Mov Disord.. 2018-05-18
10.1002/mds.27377

Lead-induced atypical Parkinsonism in rats: Behavioral, electrophysiological, and neurochemical evidence for a role of noradrenaline depletion
Mariam Sabbar, Claire Delaville, Philippe De Deurwaerdère, Nouria Lakhdar-Ghazal, Abdelhamid Benazzouz
Front. Neurosci.. 2018-03-19
10.3389/fnins.2018.00173

Inter-individual differences in the impulsive/compulsive dimension: deciphering related dopaminergic and serotonergic metabolisms at rest
Françoise Dellu-Hagedorn, Marion Rivalan, Aurélie Fitoussi, Philippe De Deurwaerdère
Phil. Trans. R. Soc. B. 2018-02-26
10.1098/rstb.2017.0154

Preferential modulation of the lateral habenula activity by serotonin-2A rather than -2C receptors: Electrophysiological and neuroanatomical evidence
Francis Delicata, Cristiano Bombardi, Massimo Pierucci, Roberto Di Maio, Philippe De Deurwaerdère, Giuseppe Di Giovanni
CNS Neurosci Ther. 2018-02-25
10.1111/cns.12830

Preferential modulation of the lateral habenula activity by serotonin‐2A rather than ‐2C receptors: Electrophysiological and neuroanatomical evidence
Francis Delicata, Cristiano Bombardi, Massimo Pierucci, Roberto Di Maio, Philippe De Deurwaerdère, Giuseppe Di Giovanni
CNS Neurosci Ther. 2018-02-25
10.1111/cns.12830

5-HT2A receptors in the basal ganglia
Cristina Miguelez, Teresa Morera-Herreras, Philippe De Deurwaerdère
5-HT2A Receptors in the Central Nervous System. 2018-01-01
10.1007/978-3-319-70474-6_12

Pharmacological analysis in favour of a physiological role for the constitutive activity of 5-HT2A receptors in learning
Philippe De Deurwaerdère, Guillaume Drutel, Giuseppe Di Giovanni
5-HT2A Receptors in the Central Nervous System. 2018-01-01
10.1007/978-3-319-70474-6_1

Role of serotonin2A (5-HT2A) receptors in epilepsy
Vincenzo Crunelli, Marcello Venzi, Philippe De Deurwaerdère, Giuseppe Di Giovanni
5-HT2A Receptors in the Central Nervous System. 2018-01-01
10.1007/978-3-319-70474-6_16

Purposeless oral activity induced by meta-chlorophenylpiperazine (m-CPP): Undefined tic-like behaviors?
Deborah S. Kreiss, Philippe De Deurwaerdère
Journal of Neuroscience Methods. 2017-12-01
10.1016/j.jneumeth.2017.05.007

Does the Serotonin2C receptor segregate circuits of the basal ganglia responding to cingulate cortex stimulation?
Mélanie Lagière, Marion Bosc, Sara Whitestone, Julien Manem, Hasna Elboukhari, Abdelhamid Benazzouz, Giuseppe Di Giovanni, Philippe De Deurwaerdère
CNS Neurosci Ther. 2017-11-15
10.1111/cns.12777

Impairment of serotonergic transmission by the antiparkinsonian drug L-DOPA: Mechanisms and clinical implications
Cristina Miguelez, Abdelhamid Benazzouz, Luisa Ugedo, Philippe De Deurwaerdère
Front. Cell. Neurosci.. 2017-09-12
10.3389/fncel.2017.00274

Serotonergic modulation of the activity of mesencephalic dopaminergic systems: Therapeutic implications
Philippe De Deurwaerdère, Giuseppe Di Giovanni
Progress in Neurobiology. 2017-04-01
10.1016/j.pneurobio.2016.03.004

Expanding the repertoire of L-DOPA's actions: A comprehensive review of its functional neurochemistry
Philippe De Deurwaerdère, Giuseppe Di Giovanni, Mark J. Millan
Progress in Neurobiology. 2017-04-01
10.1016/j.pneurobio.2016.07.002

Neurobiology and neuropharmacology of monoaminergic systems
Philippe De Deurwaerdère, Rona R. Ramsay, Giuseppe Di Giovanni
Progress in Neurobiology. 2017-04-01
10.1016/j.pneurobio.2017.02.001

Correlative analysis of dopaminergic and serotonergic metabolism across the brain to study monoaminergic function and interaction
Françoise Dellu-Hagedorn, Aurélie Fitoussi, Philippe De Deurwaerdère
Journal of Neuroscience Methods. 2017-03-01
10.1016/j.jneumeth.2017.01.020

Comparative Analysis of the Neurochemical Profile and MAO Inhibition Properties of N-(Furan-2-ylmethyl)-N-methylprop-2-yn-1-amine
Philippe De Deurwaerdère, Claudia Binda, Rémi Corne, Cosima Leone, Aurora Valeri, Massimo Valoti, Rona R. Ramsay, Yagamare Fall, José Marco-Contelles
ACS Chem. Neurosci.. 2016-12-30
10.1021/acschemneuro.6b00377

Cortico-subthalamic inputs from the motor, limbic, and associative areas in normal and dopamine-depleted rats are not fully segregated
Marcus L. F. Janssen, Yasin Temel, Claire Delaville, Daphne G. M. Zwartjes, Tjitske Heida, Philippe De Deurwaerdère, Veerle Visser-Vandewalle, Abdelhamid Benazzouz
Brain Struct Funct. 2016-12-24
10.1007/s00429-016-1351-5

Monoaminergic and histaminergic strategies and treatments in brain diseases
Giuseppe Di Giovanni, Dubravka Svob Strac, Montse Sole, Mercedes Unzeta, Keith F. Tipton, Dorotea Mück-Šeler, Irene Bolea, Laura Della Corte, Matea Nikolac Perkovic, Nela Pivac, Ilse J. Smolders, Anna Stasiak, Wieslawa A. Fogel, Philippe De Deurwaerdère
Front. Neurosci.. 2016-11-24
10.3389/fnins.2016.00541

Monoaminergic mechanisms in epilepsy may offer innovative therapeutic opportunity for monoaminergic multi-target drugs
Dubravka Svob Strac, Nela Pivac, Ilse J. Smolders, Wieslawa A. Fogel, Philippe De Deurwaerdere, Giuseppe Di Giovanni
Front. Neurosci.. 2016-11-10
10.3389/fnins.2016.00492

L-DOPA elicits non-vesicular releases of serotonin and dopamine in hemiparkinsonian rats in vivo
Cristina Miguelez, Sylvia Navailles, Claire Delaville, Loïse Marquis, Mélanie Lagière, Abdelhamid Benazzouz, Luisa Ugedo, Philippe De Deurwaerdère
European Neuropsychopharmacology. 2016-08-01
10.1016/j.euroneuro.2016.05.004

Updating neuropathology and neuropharmacology of monoaminergic systems
Rona R Ramsay, Philippe De Deurwaerdère, Giuseppe Di Giovanni
British Journal of Pharmacology. 2016-06-14
10.1111/bph.13508

The acute and long-term L-DOPA effects are independent from changes in the activity of dorsal raphe serotonergic neurons in 6-OHDA lesioned rats
C Miguelez, S Navailles, P De Deurwaerdère, L Ugedo
British Journal of Pharmacology. 2016-03-08
10.1111/bph.13447

New therapeutic opportunities for 5-HT2C receptor ligands in neuropsychiatric disorders.
Giuseppe Di Giovanni, Philippe De Deurwaerdère
Pharmacology & Therapeutics. 2016-01-01
10.1016/j.pharmthera.2015.11.009

Cariprazine: New dopamine biased agonist for neuropsychiatry disorders
B. SaiKiran
Drugs Today. 2016-01-01
10.1358/dot.2016.52.2.2461868

The impact of combined administration of paraquat and maneb on motor and non-motor functions in the rat
A. Tinakoua, S. Bouabid, E. Faggiani, P. De Deurwaerdère, N. Lakhdar-Ghazal, A. Benazzouz
Neuroscience. 2015-12-01
10.1016/j.neuroscience.2015.10.021

Monoamine content during the reproductive cycle of Perna perna depends on site of origin on the Atlantic Coast of Morocco.
Mounia S. Klouche, Philippe De Deurwaerdère, Françoise Dellu-Hagedorn, Nouria Lakhdar-Ghazal, Soumaya Benomar
Sci Rep. 2015-09-09
10.1038/srep13715

Monoamine content during the reproductive cycle of Perna perna depends on site of origin on the Atlantic Coast of Morocco
Mounia S. Klouche, Philippe De Deurwaerdère, Françoise Dellu-Hagedorn, Nouria Lakhdar-Ghazal, Soumaya Benomar
Sci Rep. 2015-09-09
10.1038/srep13715

The 5-HT4 Agonist Prucalopride Stimulates L-DOPA-Induced Dopamine Release in Restricted Brain Regions of the Hemiparkinsonian Rat In Vivo.
Sylvia Navailles, Giuseppe Di Giovanni, Philippe De Deurwaerdère
CNS Neurosci Ther. 2015-07-24
10.1111/cns.12436

The 5-HT<inf>4</inf> Agonist Prucalopride Stimulates L-DOPA-Induced Dopamine Release in Restricted Brain Regions of the Hemiparkinsonian Rat In Vivo
Sylvia Navailles, Giuseppe Di Giovanni, Philippe De Deurwaerdère
CNS Neurosci Ther. 2015-07-24
10.1111/cns.12436

Serotonin, but not dopamine, controls the stress response and anxiety-like behavior in the crayfish Procambarus clarkii.
P. Fossat, J. Bacque-Cazenave, P. De Deurwaerdere, D. Cattaert, J.-P. Delbecque
Journal of Experimental Biology. 2015-07-02
10.1242/jeb.120550

Blood withdrawal affects iron store dynamics in primates with consequences on monoaminergic system function
C. Hyacinthe, P. De Deurwaerdere, T. Thiollier, Q. Li, E. Bezard, I. Ghorayeb
Neuroscience. 2015-04-01
10.1016/j.neuroscience.2015.01.057

NMDA receptor antagonism potentiates the L-DOPA-induced extracellular dopamine release in the subthalamic nucleus of hemi-parkinson rats.
Anissa El Arfani, Eduard Bentea, Najat Aourz, Ben Ampe, Philippe De Deurwaerdère, Ann Van Eeckhaut, Ann Massie, Sophie Sarre, Ilse Smolders, Yvette Michotte
Neuropharmacology. 2014-10-01
10.1016/j.neuropharm.2014.05.024

Role(s) of the 5-HT2C receptor in the development of maximal dentate activation in the hippocampus of anesthetized rats (vol 20, pg 651, 2014)

CNS Neurosci Ther. 2014-09-26
10.1111/CNS.12324

Role(s) of the 5-HT2C receptor in the development of maximal dentate activation in the hippocampus of anesthetized rats.
Gergely Orban, Cristiano Bombardi, Antonella Marino Gammazza, Roberto Colangeli, Massimo Pierucci, Cristoforo Pomara, Mauro Pessia, Fabio Bucchieri, Benigno Arcangelo, Ilse Smolders, Philippe De Deurwaerdère, Giuseppe Di Giovanni
CNS Neurosci Ther. 2014-06-17
10.1111/cns.12285

Role(s) of the 5-HT2C receptor in the development of maximal dentate activation in the hippocampus of anesthetized rats
Gergely Orban, Cristiano Bombardi, Antonella Marino Gammazza, Roberto Colangeli, Massimo Pierucci, Cristoforo Pomara, Mauro Pessia, Fabio Bucchieri, Benigno Arcangelo, Ilse Smolders, Philippe De Deurwaerdère, Giuseppe Di Giovanni
CNS Neurosci Ther. 2014-06-17
10.1111/cns.12285

Anxiety-like behavior in crayfish is controlled by serotonin
P. Fossat, J. Bacque-Cazenave, P. De Deurwaerdere, J.-P. Delbecque, D. Cattaert
Science. 2014-06-12
10.1126/science.1248811

Manganese-induced atypical parkinsonism is associated with altered Basal Ganglia activity and changes in tissue levels of monoamines in the rat.
Safa Bouabid, Claire Delaville, Philippe De Deurwaerdère, Nouria Lakhdar-Ghazal, Abdelhamid Benazzouz
PLoS ONE. 2014-06-04
10.1371/journal.pone.0098952

N-(furan-2-ylmethyl)-N-methylprop-2-yn-1-amine (F2MPA): A potential cognitive enhancer with MAO inhibitor properties.
Giuseppe Di Giovanni, Isela García, Roberto Colangeli, Massimo Pierucci, Marcos L. Rivadulla, Elena Soriano, Mourad Chioua, Laura Della Corte, Matilde Yáñez, Philippe De Deurwaerdère, Yagamare Fall, José Marco-Contelles
CNS Neurosci Ther. 2014-05-21
10.1111/cns.12284

N-(furan-2-ylmethyl)-N-methylprop-2-yn-1-amine (F2MPA): A potential cognitive enhancer with MAO inhibitor properties
Giuseppe Di Giovanni, Isela García, Roberto Colangeli, Massimo Pierucci, Marcos L. Rivadulla, Elena Soriano, Mourad Chioua, Laura Della Corte, Matilde Yáñez, Philippe De Deurwaerdère, Yagamare Fall, José Marco-Contelles
CNS Neurosci Ther. 2014-05-21
10.1111/cns.12284

Noradrenergic terminals regulate L-DOPA-derived dopamine extracellular levels in a region-dependent manner in Parkinsonian rats.
Sylvia Navailles, Léa Milan, Hanane Khalki, Giuseppe Di Giovanni, Mélanie Lagière, Philippe De Deurwaerdère
CNS Neurosci Ther. 2014-04-28
10.1111/cns.12275

Noradrenergic terminals regulate l-DOPA-derived dopamine extracellular levels in a region-dependent manner in Parkinsonian rats
Sylvia Navailles, Léa Milan, Hanane Khalki, Giuseppe Di Giovanni, Mélanie Lagière, Philippe De Deurwaerdère
CNS Neurosci Ther. 2014-04-28
10.1111/cns.12275

Predicting dopaminergic effects of L-DOPA in the treatment for Parkinson's disease.
Sylvia Navailles, Giuseppe Di Giovanni, Philippe De Deurwaerdère
CNS Neurosci Ther. 2014-03-15
10.1111/cns.12252

Predicting dopaminergic effects of L-DOPA in the treatment for Parkinson's disease
Sylvia Navailles, Giuseppe Di Giovanni, Philippe De Deurwaerdère
CNS Neurosci Ther. 2014-03-15
10.1111/cns.12252

L-DOPA and the Brain Pattern of Dopamine Extracellular Levels: A New Deal Imposed by Serotonergic and Noradrenergic Fibres
Philippe De Deurwaerdère, Sylvia Navailles, Léa Milan
Catecholamine Research in the 21st Century. 2014-01-01
10.1016/B978-0-12-800044-1.00221-X

Role of central serotonin receptors in nicotine addiction
Massimo Pierucci, Stephanie Chambers, Lucy Partridge, Philippe De Deurwaerdère, Giuseppe Di Giovanni
Nicotinic Receptors. 2014-01-01
10.1007/978-1-4939-1167-7_14

Monoamines tissue content analysis reveals restricted and site-specific correlations in brain regions involved in cognition
A. Fitoussi, F. Dellu-Hagedorn, P. De Deurwaerdère
Neuroscience. 2013-12-01
10.1016/j.neuroscience.2013.09.059

Serotonin2c receptor constitutive activity: in vivo direct and indirect evidence and functional significance.
Sylvia Navailles, Mélanie Lagière, Martin Guthrie, Philippe Deurwaerdère
CNSAMC. 2013-10-01
10.2174/1871524911313020002

A tobacco extract containing alkaloids induces distinct effects compared to pure nicotine on dopamine release in the rat.
Hanane Khalki, Sylvia Navailles, Camille L. Piron, Philippe De Deurwaerdère
Neuroscience Letters. 2013-06-01
10.1016/j.neulet.2013.03.047

Role of 5-HT2C receptors in the enhancement of c-Fos expression induced by a 5-HT2B/2C inverse agonist and 5-HT2 agonists in the rat basal ganglia
S. Navailles, M. Lagière, C. Le Moine, P. De Deurwaerdère
Exp Brain Res. 2013-05-17
10.1007/s00221-013-3562-9

Multiple controls exerted by 5-HT2C receptors upon basal ganglia function: From physiology to pathophysiology
P. De Deurwaerdère, M. Lagière, M. Bosc, S. Navailles
Exp Brain Res. 2013-04-25
10.1007/s00221-013-3508-2

Multisite Intracerebral Microdialysis to Study the Mechanism of L-DOPA Induced Dopamine and Serotonin Release in the Parkinsonian Brain
S. Navailles, M. Lagière, A. Contini, P. De Deurwaerdère
ACS Chem. Neurosci.. 2013-04-15
10.1021/CN400046E

Serotonin2C ligands exhibiting full negative and positive intrinsic activity elicit purposeless oral movements in rats: distinct effects of agonists and inverse agonists in a rat model of Parkinson's disease.
Sylvia Navailles, Mélanie Lagière, Audrey Roumegous, Marina Polito, Méric B. Boujema, Martine Cador, John Dunlop, Marie-Françoise Chesselet, Mark J. Millan, Philippe De Deurwaerdère
International Journal of Neuropsychopharmacology. 2013-04-01
10.1017/S1461145712000417

Intrapallidal administration of 6-hydroxydopamine mimics in large part the electrophysiological and behavioral consequences of major dopamine depletion in the rat
P.M. Abedi, C. Delaville, P. De Deurwaerdère, W. Benjelloun, A. Benazzouz
Neuroscience. 2013-04-01
10.1016/j.neuroscience.2013.01.043

Serotonin2C ligands exhibiting full negative and positive intrinsic activity elicit purposeless oral movements in rats: Distinct effects of agonists and inverse agonists in a rat model of Parkinson's disease
Sylvia Navailles, Mélanie Lagière, Audrey Roumegous, Marina Polito, Méric B. Boujema, Martine Cador, John Dunlop, Marie-Françoise Chesselet, Mark J. Millan, Philippe De Deurwaerdère
International Journal of Neuropsychopharmacology. 2013-04-01
10.1017/S1461145712000417

The enhanced oral response to the 5-HT2 agonist Ro 60-0175 in parkinsonian rats involves the entopeduncular nucleus: Electrophysiological correlates
M. Lagière, S. Navailles, L. Mignon, A. Roumegous, M.-F. Chesselet, P. De Deurwaerdère
Exp Brain Res. 2013-03-28
10.1007/s00221-013-3478-4

Serotonin2C Receptors and the Motor Control of Oral Activity.
Melanie Lagiere, Sylvia Navailles, Marion Bosc, Martin Guthrie, Philippe Deurwaerdere
CN. 2013-03-01
10.2174/1570159X11311020003

Catecholamine/Serotonin interactions: systems thinking for brain function and disease.
Julie G. Hensler, Francesc Artigas, Analía Bortolozzi, Lynette C. Daws, Philippe De Deurwaerdère, Léa Milan, Sylvia Navailles, Wouter Koek
A New Era of Catecholamines in the Laboratory and Clinic. 2013-01-01
10.1016/B978-0-12-411512-5.00009-9

MANGANESE NEUROTOXICITY INDUCES ATYPICAL PARKINSONISM IN THE RAT
Bouabid Safa, Delaville Claire, De Deurwaerdere Philippe, Lakhdar Ghazal Nouria, Benazzouz Abdelhamid
Front. Hum. Neurosci.. 2013-01-01
10.3389/CONF.FNHUM.2013.210.00009

What can we expect from the serotonergic side of l-DOPA? | Que pouvons-nous attendre de la composante sérotoninergique de la l-DOPA ?
P. De Deurwaerdère, S. Navailles
Revue Neurologique. 2012-12-01
10.1016/j.neurol.2012.01.585

Lead intoxication induces noradrenaline depletion, motor nonmotor disabilities, and changes in the firing pattern of subthalamic nucleus neurons
M. Sabbar, C. Delaville, P. De Deurwaerdère, A. Benazzouz, N. Lakhdar-Ghazal
Neuroscience. 2012-05-01
10.1016/j.neuroscience.2012.02.026

Emerging dysfunctions consequent to combined monoaminergic depletions in parkinsonism
Claire Delaville, Jonathan Chetrit, Khaled Abdallah, Stéphanie Morin, Laura Cardoit, Philippe De Deurwaerdère, Abdelhamid Benazzouz
Neurobiology of Disease. 2012-02-01
10.1016/j.nbd.2011.10.023

Contribution of serotonergic transmission to the motor and cognitive effects of high-frequency stimulation of the subthalamic nucleus or levodopa in Parkinson's disease
Sylvia Navailles, Philippe De Deurwaerdère
Mol Neurobiol. 2012-01-06
10.1007/s12035-011-8230-0

Imbalanced Dopaminergic Transmission Mediated by Serotonergic Neurons in L-DOPA-Induced Dyskinesia
Sylvia Navailles, Philippe De Deurwaerdère
Parkinson's Disease. 2012-01-01
10.1155/2012/323686

L-DOPA and serotonergic neurons: functional implication and therapeutic perspectives in Parkinson's disease.
Sylvia Navailles, Manolo Carta, Martin Guthrie, Philippe De Deurwaerdere
CNSAMC. 2011-12-01
10.2174/1871524911106040305

Chronic L-DOPA therapy alters central serotonergic function and L-DOPA-induced dopamine release in a region-dependent manner in a rat model of Parkinson's disease
Sylvia Navailles, Bernard Bioulac, Christian Gross, Philippe De Deurwaerdère
Neurobiology of Disease. 2011-02-01
10.1016/j.nbd.2010.11.007

Noradrenaline and Parkinson's disease
Claire Delaville, Philippe De Deurwaerdère, Abdelhamid Benazzouz
Front. Syst. Neurosci.. 2011-01-01
10.3389/fnsys.2011.00031

Physiological and Pathophysiological Aspects of 5-HT2c Receptors in Basal Ganglia
Philippe De Deurwaerdère, Laurence Mignon, Marie-Françoise Chesselet
The Receptors. 2010-11-10
10.1007/978-1-60761-941-3_18

The Constitutive Activity of 5-HT2C Receptors as an Additional Modality of Interaction of the Serotonergic System
Sylvia Navailles, Philippe De Deurwaerdère
The Receptors. 2010-11-10
10.1007/978-1-60761-941-3_10

Presynaptic control of serotonin on striatal dopamine function
Sylvia Navailles, Philippe De Deurwaerdère
Psychopharmacology. 2010-10-16
10.1007/s00213-010-2029-y

Serotonergic neurons mediate ectopic release of dopamine induced by l-DOPA in a rat model of Parkinson's disease
Sylvia Navailles, Bernard Bioulac, Christian Gross, Philippe De Deurwaerdère
Neurobiology of Disease. 2010-04-01
10.1016/j.nbd.2010.01.012

High-frequency stimulation of the subthalamic nucleus and L-3,4-dihydroxyphenylalanine inhibit in vivo serotonin release in the prefrontal cortex and hippocampus in a rat model of Parkinson's disease
S. Navailles, A. Benazzouz, B. Bioulac, C. Gross, P. De Deurwaerdere
Journal of Neuroscience. 2010-02-10
10.1523/JNEUROSCI.5031-09.2010

Clozapine and haloperidol differentially alter the constitutive activity of central serotonin2C receptors in vivo
Sylvia Navailles, Philippe De Deurwaerdère, Umberto Spampinato
Biological Psychiatry. 2006-03-01
10.1016/j.biopsych.2005.07.035

Clozapine and haloperidol differentially alter the constitutive activity of central serotonin2C receptors in vivo
Sylvia Navailles, Philippe De Deurwaerdère, Umberto Spampinato
Biological Psychiatry. 2006-03-01
10.1016/j.biopsych.2005.07.035

Regionally and functionally distinct serotonin3 receptors control in vivo dopamine outflow in the rat nucleus accumbens
Philippe De Deurwaerdere, Delphine Moison, Sylvia Navailles, Gregory Porras, Umberto Spampinato
J Neurochem. 2005-07-01
10.1111/j.1471-4159.2005.03174.x

Constitutive Activity of the Serotonin2C Receptor Inhibits In Vivo Dopamine Release in the Rat Striatum and Nucleus Accumbens
P. De Deurwaerdere
Journal of Neuroscience. 2004-03-31
10.1523/JNEUROSCI.0112-04.2004

Intrastriatal administration of sigma ligands inhibits basal dopamine release in vivo
D Moison
Neuropharmacology. 2003-12-01
10.1016/S0028-3908(03)00253-3

In Vivo Evidence that 5-HT2C Receptor Antagonist but not Agonist Modulates Cocaine-Induced Dopamine Outflow in the Rat Nucleus Accumbens and Striatum
Sylvia Navailles, Philippe De Deurwaerdère, Grégory Porras, Umberto Spampinato
Neuropsychopharmacol. 2003-10-15
10.1038/sj.npp.1300329

In Vivo Evidence that 5-HT2C Receptor Antagonist but not Agonist Modulates Cocaine-Induced Dopamine Outflow in the Rat Nucleus Accumbens and Striatum
Sylvia Navailles, Philippe De Deurwaerdère, Grégory Porras, Umberto Spampinato
Neuropsychopharmacol. 2003-10-15
10.1038/sj.npp.1300329

Selective serotonin reuptake inhibitors enhance cocaine-induced locomotor activity and dopamine release in the nucleus accumbens
M.J Bubar, L.R McMahon, P De Deurwaerdère, U Spampinato, K.A Cunningham
Neuropharmacology. 2003-03-01
10.1016/S0028-3908(02)00381-7

Conditional involvement of striatal serotonin3 receptors in the control of in vivo dopamine outflow in the rat striatum
Grégory Porras, Philippe De Deurwaerdère, Delphine Moison, Umberto Spampinato
European Journal of Neuroscience. 2003-02-01
10.1046/j.1460-9568.2003.02512.x

Central serotonin4 receptors selectively regulate the impulse-dependent exocytosis of dopamine in the rat striatum: In vivo studies with morphine, amphetamine and cocaine
Grégory Porras, Vincenzo Di Matteo, Philippe De Deurwaerdère, Ennio Esposito, Umberto Spampinato
Neuropharmacology. 2002-12-01
10.1016/S0028-3908(02)00212-5

Central serotonin4 receptors selectively regulate the impulse-dependent exocytosis of dopamine in the rat striatum: In vivo studies with morphine, amphetamine and cocaine
Grégory Porras, Vincenzo Di Matteo, Philippe De Deurwaerdère, Ennio Esposito, Umberto Spampinato
Neuropharmacology. 2002-12-01
10.1016/S0028-3908(02)00212-5

Central 5-HT4 receptors and dopamine-dependent motor behaviors: Searching for a functional role
Philippe De Deurwaerdère, Luigi Cervo, Luis Stinus, Umberto Spampinato
Pharmacology Biochemistry and Behavior. 2002-04-01
10.1016/S0091-3057(01)00703-1

Central 5-HT4 receptors and dopamine-dependent motor behaviors: Searching for a functional role
Philippe De Deurwaerdère, Luigi Cervo, Luis Stinus, Umberto Spampinato
Pharmacology Biochemistry and Behavior. 2002-04-01
10.1016/S0091-3057(01)00703-1

5-HT2A and 5-HT2C/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum
G Porras
Neuropsychopharmacology. 2002-03-01
10.1016/S0893-133X(01)00333-5

5-HT2A and 5-HT2C/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum
G Porras
Neuropsychopharmacology. 2002-03-01
10.1016/S0893-133X(01)00333-5

D-amphetamine-induced behavioral sensitization: Effect of lesioning dopaminergic terminals in the medial prefrontal cortex, the amygdala and the entorhinal cortex
Y Bjijou, P De Deurwaerdere, U Spampinato, L Stinus, M Cador
Neuroscience. 2002-02-01
10.1016/S0306-4522(01)00508-5

Role of serotonin(2A) and serotonin(2B/2C) receptor subtypes in the control of accumbal and striatal dopamine release elicited in vivo by dorsal raphe nucleus electrical stimulation
Philippe De Deurwaerdère, Umberto Spampinato
Journal of Neurochemistry. 2001-12-25
10.1046/j.1471-4159.1999.0731033.x

The nigrostriatal dopamine system: A neglected target for 5-HT2C receptors (1)
Philippe De Deurwaerdère, Umberto Spampinato
Trends in Pharmacological Sciences. 2001-10-01
10.1016/S0165-6147(00)01811-3

The nigrostriatal dopamine system: A neglected target for 5-HT2C receptors [1]
Philippe De Deurwaerdère, Umberto Spampinato
Trends in Pharmacological Sciences. 2001-10-01
10.1016/S0165-6147(00)01811-3

Neurochemical and electrophysiological evidence that 5-HT4 receptors exert a state-dependent facilitatory control in vivo on nigrostriatal, but not mesoaccumbal, dopaminergic function
Guillaume Lucas, Vincenzo Di Matteo, Philippe De Deurwaerdère, Grégory Porras, Raúl Martín-Ruiz, Francesc Artigas, Ennio Esposito, Umberto Spampinato
European Journal of Neuroscience. 2001-03-01
10.1046/j.0953-816X.2000.01453.x

Endogenous serotonin enhances the release of dopamine in the striatum only when nigro-striatal dopaminergic transmission is activated
Guillaume Lucas, Philippe De Deurwaerdère, Grégory Porras, Umberto Spampinato
Neuropharmacology. 2000-10-01
10.1016/S0028-3908(00)00020-4

Nigrostriatal lesions alter oral dyskinesia and c-Fos expression induced by the serotonin agonist 1-(m-chlorophenyl)piperazine in adult rats
Philippe De Deurwaerdère, Marie-Françoise Chesselet
J. Neurosci.. 2000-07-01
10.1523/JNEUROSCI.20-13-05170.2000

The effect of serotonergic agents on haloperidol-induced striatal dopamine release in vivo: Opposite role of 5-HT(2A) and 5-HT(2C) receptor subtypes and significance of the haloperidol dose used
Guillaume Lucas, Philippe De Deurwaerdère, Silvio Caccia, Umberto Spampinato
Neuropharmacology. 2000-05-01
10.1016/S0028-3908(99)00193-8

The effect of serotonergic agents on haloperidol-induced striatal dopamine release in vivo: opposite role of 5-HT2A and 5-HT2C receptor subtypes and significance of the haloperidol dose used
Guillaume Lucas, Philippe De Deurwaerdère, Silvio Caccia, Umberto Spampinato
Neuropharmacology. 2000-05-01
10.1016/S0028-3908(99)00193-8

Selective blockade of serotonin-2C/2B receptors enhances mesolimbic and mesostriatal dopaminergic function: A combined in vivo electrophysiological and microdialysis study
G Di Giovanni, P De Deurwaerdére, M Di Mascio, V Di Matteo, E Esposito, U Spampinato
Neuroscience. 1999-06-01
10.1016/S0306-4522(98)00655-1

Opposite change of in vivo dopamine release in the rat nucleus accumbens and striatum that follows electrical stimulation of dorsal raphe nucleus: Role of 5-HT3 receptors
Philippe De Deurwaerdère, Luis Stinus, Umberto Spampinato
J. Neurosci.. 1998-08-15
10.1523/JNEUROSCI.18-16-06528.1998

8-OH-DPAT, a 5-HT(1a) agonist and ritanserin, a 5-HT(2A/C) antagonist, reverse haloperidol-induced catalepsy in rats independently of striatal dopamine release
Guillaume Lucas, Norbert Bonhomme, Philippe De Deurwaerdère, Michel Le Moal, U. Spampinato
Psychopharmacology. 1997-05-15
10.1007/s002130050265

Serotonin stimulation of 5-HT4 receptors indirectly enhances in vivo dopamine release in the rat striatum
Philippe De Deurwaerdère, Marie L'hirondel, Norbert Bonhomme, Guillaume Lucas, André Cheramy, Umberto Spampinato
Journal of Neurochemistry. 1997-01-01
10.1046/J.1471-4159.1997.68010195.X

Serotonin enhances striatal dopamine outflow in vivo through dopamine uptake sites
Philippe De Deurwaerdère, Norbert Bonhomme, Guillaume Lucas, Michel Le Moal, Umberto Spampinato
Journal of Neurochemistry. 1996-01-01
10.1046/J.1471-4159.1996.66010210.X

d-Fenfluramine Increases Striatal Extracellular Dopamine In Vivo Independently of Serotonergic Terminals or Dopamine Uptake Sites
Philippe De Deurwaerdère, Norbert Bonhomme, Michel Le Moal, Umberto Spampinato
Journal of Neurochemistry. 1995-09-01
10.1046/J.1471-4159.1995.65031100.X

Evidence for 5-HT4 receptor subtype involvement in the enhancement of striatal dopamine release induced by serotonin: a microdialysis study in the halothane-anesthetized rat
N. Bonhomme, P. De Deurwaèrdere, M. Le Moal, U. Spampinato
Neuropharmacology. 1995-03-01
10.1016/0028-3908(94)00145-I